Fasoracetam CAS 110958-19-5 Nootropics Raw Powder

Fasoracetam CAS 110958-19-5 Nootropics Raw Powder

Fasoracetam Basic Info

Description:

Fasoracetam is a research chemical of the racetam family.It is a nootropic, and has been in clinical trials for vascular dementia and attention deficit hyperactivity disorder.
Fasoracetam appears to agonize all three metabotropic glutamate receptors and has improved cognitive function in rodent studies.It is orally available and is excreted mostly unchanged via the urine. Fasoracetam was discovered by scientists at the Japanese pharmaceutical company Nippon Shinyaku, which brought it through Phase 3 clinical trials for vascular dementia, and abandoned it due to lack of efficacy.

Fasoracetam (NS-105/LAM-105) is a relatively new Piracetam-like nootropic, which, as the name suggests, belongs to the racetam family of nootropics. Fasoracetam is a very potent racetam with a great potential as a cognitive enhancer. It has a chemical structure of (5R)-5-(piperidine-1-carbonyl) pyrrolidin-2-one and was originally developed by a company called Nippon Shinyaku in search for the treatment of Alzheimer’s disease. Fasoracetam is highly attractive to college students and anyone who has a fast-paced life that calls for multi-tasking. Many want to get ahead, retain more information, maintain the knowledge they gather and have a good recall of everything that they need to recall.

COA